These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The Ca2+ release activities of D-myo-inositol 1,4,5-trisphosphate analogs are quantized. Denis GV; Ballou CE Cell Calcium; 1991 Jun; 12(6):395-401. PubMed ID: 1884394 [TBL] [Abstract][Full Text] [Related]
23. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor. Safrany ST; Sawyer DA; Nahorski SR; Potter BV Chirality; 1992; 4(7):415-22. PubMed ID: 1334423 [TBL] [Abstract][Full Text] [Related]
24. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor. Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304 [TBL] [Abstract][Full Text] [Related]
25. Pretreatment with D-myo-inositol trisphosphate reduces infarct size in rabbit hearts: role of inositol trisphosphate receptors and gap junctions in triggering protection. Przyklenk K; Maynard M; Darling CE; Whittaker P J Pharmacol Exp Ther; 2005 Sep; 314(3):1386-92. PubMed ID: 15919762 [TBL] [Abstract][Full Text] [Related]
26. D-myo-inositol 1,4,5-trisphosphate analogues substituted at the 3-hydroxyl group. Hirata M; Watanabe Y; Kanematsu T; Ozaki S; Koga T Biochim Biophys Acta; 1995 Jun; 1244(2-3):404-10. PubMed ID: 7599161 [TBL] [Abstract][Full Text] [Related]
27. C-glycoside based mimics of D-myo-inositol 1,4,5-trisphosphate. Rosenberg HJ; Riley AM; Correa V; Taylor CW; Potter BV Carbohydr Res; 2000 Oct; 329(1):7-16. PubMed ID: 11086681 [TBL] [Abstract][Full Text] [Related]
28. Synthesis of racemic 5-phosphonate analogues of myo-inositol 1,4,5-tris- and 1,3,4,5-tetrakis-phosphate. Dreef CE; Jansze JP; Elie CJ; van der Marel GA; van Boom JH Carbohydr Res; 1992 Oct; 234():37-50. PubMed ID: 1468080 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and binding properties of cyclopentane analogues of myo-inositol 1,4,5-tris(phosphate). Moris MA; Caron AZ; Guillemette G; Schlewer G Bioorg Med Chem; 2004 Aug; 12(15):3995-4001. PubMed ID: 15246076 [TBL] [Abstract][Full Text] [Related]
30. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase. Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077 [TBL] [Abstract][Full Text] [Related]
31. Hydrophobic modifications at 1-phosphate of inositol 1,4,5-trisphosphate analogues enhance receptor binding. Nakanishi W; Kikuchi K; Inoue T; Hirose K; Iino M; Nagano T Bioorg Med Chem Lett; 2002 Mar; 12(6):911-3. PubMed ID: 11958992 [TBL] [Abstract][Full Text] [Related]
32. New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor. Wilcox RA; Primrose WU; Nahorski SR; Challiss RA Trends Pharmacol Sci; 1998 Nov; 19(11):467-75. PubMed ID: 9850611 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor. Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of the type 1 inositol 1,4,5-trisphosphate receptor by 2-aminoethoxydiphenylborate. Bilmen JG; Michelangeli F Cell Signal; 2002 Nov; 14(11):955-60. PubMed ID: 12220621 [TBL] [Abstract][Full Text] [Related]
36. An analysis of myo-[3H]inositol trisphosphates found in myo-[3H]inositol prelabelled avian erythrocytes. Stephens LR; Hawkins PT; Downes CP Biochem J; 1989 Sep; 262(3):727-37. PubMed ID: 2590163 [TBL] [Abstract][Full Text] [Related]
37. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate. Wilcox RA; Whitham EM; Liu C; Potter BV; Nahorski SR FEBS Lett; 1993 Dec; 336(2):267-71. PubMed ID: 8262243 [TBL] [Abstract][Full Text] [Related]
38. Rapid activation and partial inactivation of inositol trisphosphate receptors by adenophostin A. Adkins CE; Wissing F; Potter BV; Taylor CW Biochem J; 2000 Dec; 352 Pt 3(Pt 3):929-33. PubMed ID: 11104705 [TBL] [Abstract][Full Text] [Related]
39. Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity. Riley AM; Correa V; Mahon MF; Taylor CW; Potter BV J Med Chem; 2001 Jun; 44(13):2108-17. PubMed ID: 11405648 [TBL] [Abstract][Full Text] [Related]
40. Ionization state of myo-inositol 1,4,5-trisphosphate: correlation with binding properties. Schmitt L; Schlewer G; Spiess B Biochim Biophys Acta; 1991 Oct; 1075(2):139-40. PubMed ID: 1657174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]